News und Analysen
Western Union to Present at the Wolfe FinTech Forum
The Western Union Company (NYSE: WU), a global leader in cross-border, cross-currency money movement and payments, today announced that the Company will present at the Wolfe FinTech Forum on
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
SunOpta Announces Fourth Quarter and Fiscal 2021 Financial Results
SunOpta Inc. (“SunOpta” or the “Company”) (Nasdaq:STKL) (TSX:SOY), a leading healthy food and beverage company focused on plant-based foods and beverages and fruit-based foods and beverages, today
New Data Finds Tumor Treating Fields Initiates Downstream Anti-Tumor Response
Novocure (NASDAQ: NVCR) today announced that a new study published in the Journal of Clinical Investigation (JCI) finds treatment with Tumor Treating Fields (TTFields) mediated cell disruption
Lawson Products Reports Fourth Quarter and Full Year 2021 Results
Lawson Products, Inc. (NASDAQ:LAWS) ("Lawson" or the "Company"), a distributor of products and services to the MRO marketplace, today announced results for the fourth quarter and the full year
Novocure Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Company Update
Novocure (NASDAQ: NVCR) today reported financial results for the fourth quarter and full year ended December 31, 2021. Novocure is a global oncology company working to extend survival in some of
NICE Recognized as a Top Provider for Conversational AI Applications and Chatbots by Metrigy
NICE (Nasdaq: NICE) today announced that it has been recognized as a MetriStar Top Provider in the Conversational AI Applications category, out of a total of 23 companies evaluated. The ranking was
Lysogene Provides Update on Efficacy, Safety and Timelines of the AAVance Phase 2/3 Clinical Trial with Gene Therapy LYS-SAF302 for the Treatment of MPSIIIA
Regulatory News:
Lysogene (FR0013233475 – LYS), a phase 3 gene therapy platform company targeting central nervous system (CNS) diseases, today provides an update on clinical results and timelines
SES Full Year 2021 Results
SES S.A. announces financial results for the year ended 31 December 2021.
Solid performance delivering revenue of €1,782 million and Adjusted EBITDA(1) of €1,091 million at top end of financial
DGAP-News: Lloyds Banking Group PLC: 2021 Full Year Results
DGAP-News: Lloyds Banking Group PLC: 2021 Full Year Results
DGAP-News: Lloyds Banking Group PLC: 2021 Annual Report and Accounts
DGAP-News: Lloyds Banking Group PLC: 2021 Annual Report and Accounts
DGAP-News: AIXTRON: Weiteres Wachstum in allen Dimensionen / 65% mehr Aufträge, 59% höhere Umsätze in 2021 / Rekordumsatz in Q4/21 / Zweistelliges Wachstum für 2022 / Hohe EU-Taxonomie-Konformität
DGAP-News: AIXTRON: Weiteres Wachstum in allen Dimensionen / 65% mehr Aufträge, 59% höhere Umsätze in 2021 / Rekordumsatz in Q4/21 / Zweistelliges Wachstum für 2022 / Hohe EU-Taxonomie-Konformität
DGAP-News: AIXTRON: Continued growth in all dimensions / 65% more orders and 59% higher revenues in 2021 / Record shipments in Q4/21 / Double-digit growth for 2022 / High EU taxonomy aligned figures
DGAP-News: AIXTRON: Continued growth in all dimensions / 65% more orders and 59% higher revenues in 2021 / Record shipments in Q4/21 / Double-digit growth for 2022 / High EU taxonomy aligned figures
DGAP-News: Krones AG: Krones significantly increases revenue, order intake and profitability in 2021
DGAP-News: Krones AG: Krones steigert Umsatz, Auftragseingang und Ertragskraft 2021 deutlich
CI Financial Reports Total Assets of $372.5 Billion for January 2022
CI Financial Corp. (“CI”) (TSX: CIX, NYSE: CIXX) today reported preliminary assets under management as at January 31, 2022 of $146.4 billion and wealth management assets of $226.1 billion, for
TechnipFMC Announces Fourth Quarter 2021 Results
TechnipFMC plc (NYSE: FTI) today reported fourth quarter 2021 results.
Summary Financial Results from Continuing Operations - Fourth Quarter 2021
Reconciliation of U.S. GAAP to non-GAAP financial
TechnipFMC Announces Fourth Quarter 2021 Results
TechnipFMC plc (NYSE: FTI) today reported fourth quarter 2021 results.
Summary Financial Results from Continuing Operations - Fourth Quarter 2021
Reconciliation of U.S. GAAP to non-GAAP financial
TechnipFMC Announces Fourth Quarter 2021 Results
TechnipFMC plc (NYSE: FTI) today reported fourth quarter 2021 results.
Summary Financial Results from Continuing Operations - Fourth Quarter 2021
Reconciliation of U.S. GAAP to non-GAAP financial
Xencor Reports Fourth Quarter and Full Year 2021 Financial Results
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today reported financial